$BBIO
BridgeBio Pharma Inc
PRICE
$16.75 ▲12.416%
Extented Hours
VOLUME
9,501,471
DAY RANGE
11.75 - 14.9
52 WEEK
4.98 - 19.95
Join Discuss about BBIO with like-minded investors
@singletary #StockTraders.NET
$BBIO was could have been the biggest. straight down after the little push. wish I could of held swings longer
64 Replies 12 👍 10 🔥
@singletary #StockTraders.NET
wish I actively traded that NURO channel back and forth all day. would of added up same with BBIO. those channels all day
136 Replies 10 👍 12 🔥
@singletary #StockTraders.NET
$BBIO fully covered. great swing. I want full bp next 2 days
60 Replies 9 👍 8 🔥
Key Metrics
Market Cap
2.26 B
Beta
2.13
Avg. Volume
5.42 M
Shares Outstanding
151.37 M
Yield
0%
Public Float
0
Next Earnings Date
2023-05-04
Next Dividend Date
Company Information
BridgeBio Pharma Inc. is a team of experienced drug discoverers, developers and innovators working to create life-altering medicines that target well-characterized genetic diseases at their source. BridgeBio was founded in 2015 to identify and advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. BridgeBio's pipeline of over 20 development programs includes product candidates ranging from early discovery to late-stage development.
CEO: Neil Kumar
Website: bridgebio.com
HQ: 421 Kipling St Palo Alto, 94301-1530 California
Related News